CaixaBank, S.A.’s Elicio Therapeutics ELTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12K Hold
6,600
– – ﹤0.01% 466
2026
Q2
$25.8K Hold
6,600
– – ﹤0.01% 456
2026
Q1
$70.6K Buy
6,600
+1,000
+18% +$9.7K ﹤0.01% 441
2025
Q4
$44.6K Buy
5,600
+1,600
+40% +$14.5K ﹤0.01% 440
2025
Q3
$43.8K Buy
+4,000
New +$40.5K ﹤0.01% 443

Other funds holding ELTX

CaixaBank, S.A.'s ELTX Position: Q3 2026 in Review

CaixaBank, S.A. held its Elicio Therapeutics (ELTX) position steady in Q3 2026 at 6,600 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

CaixaBank, S.A. first reported a position in ELTX in Q3 2025 and has held it in 5 quarters since. The position peaked at $70.6K in Q1 2026. 78 funds tracked by Wall St. Rank hold ELTX as of Q3 2026.

  • CaixaBank, S.A. held 6,600 shares of Elicio Therapeutics worth $12K as of Q3 2026.
  • CaixaBank, S.A. left its Elicio Therapeutics share count unchanged in Q3 2026.
  • Elicio Therapeutics made up ﹤0.01% of CaixaBank, S.A.'s portfolio in Q3 2026, its #466 holding.
  • CaixaBank, S.A. first reported a position in Elicio Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • CaixaBank, S.A.'s Elicio Therapeutics position peaked at $70.6K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q3 2026.

Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.